ABOUT THE SERVICE
Spravato® is an esketamine nasal spray approved for the treatment of treatment-resistant depression. At Prime Psychiatry, we provide Spravato® treatment in a clinical setting, offering a rapid and effective path to improved mental well-being. This service is administered under the close supervision of our experienced medical team.
Information is owner-confirmed
Last updated 5 months ago
Price range
Other products/services from Prime Psychiatry
TMS Therapy
Mental Health Care
N/A
Prime Psychiatry
United States (US)